Kim Forest Enterprise Co., Ltd. (TPE:6645)
Taiwan · Delayed Price · Currency is TWD 13.05
+0.20 (1.56%)
Aug 19, 2026, 10:46 AM CST
Kim Forest Enterprise Market Cap
Kim Forest Enterprise has a market cap or net worth of 775.93 million as of August 18, 2026. Its market cap has decreased by -34.03% in one year.
Market Cap
775.93M
Enterprise Value
1.17B
Revenue
599.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.05
ChartMarket Cap Chart
Since August 18, 2017, Kim Forest Enterprise's market cap has increased from 545.05M to 775.93M, an increase of 42.36%. That is a compound annual growth rate of 4.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 775.93M | -27.69% |
| Dec 31, 2025 | 1.07B | -16.65% |
| Dec 31, 2024 | 1.29B | -24.16% |
| Dec 29, 2023 | 1.70B | 21.03% |
| Dec 30, 2022 | 1.40B | 32.47% |
| Dec 30, 2021 | 1.06B | -29.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BIONET | 3.09B |
| DIVA Laboratories | 1.94B |
| Puriblood Medical | 1.11B |
| Genetics Generation Advancement | 1.07B |
| Sofiva Genomics | 726.62M |
| TFBS Bioscience | 686.55M |
| Welgene Biotech | 390.35M |
| Pharmigene | 371.42M |